A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or Metastatic Neuroendocrine Non–Small-Cell Lung Cancer
医学
依托泊苷
耐受性
肺癌
肿瘤科
内科学
顺铂
化疗
不利影响
作者
Kyle Concannon,Bonnie S. Glisson,Robert C. Doebele,Chao Huang,Marcelo Marotti,D. Ross Camidge,John V. Heymach